230 related articles for article (PubMed ID: 35831503)
1. ZBTB46 defines and regulates ILC3s that protect the intestine.
Zhou W; Zhou L; Zhou J; ; Chu C; Zhang C; Sockolow RE; Eberl G; Sonnenberg GF
Nature; 2022 Sep; 609(7925):159-165. PubMed ID: 35831503
[TBL] [Abstract][Full Text] [Related]
2. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut.
Lyu M; Suzuki H; Kang L; Gaspal F; Zhou W; Goc J; Zhou L; Zhou J; Zhang W; ; Shen Z; Fox JG; Sockolow RE; Laufer TM; Fan Y; Eberl G; Withers DR; Sonnenberg GF
Nature; 2022 Oct; 610(7933):744-751. PubMed ID: 36071169
[TBL] [Abstract][Full Text] [Related]
3. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.
Klose CS; Kiss EA; Schwierzeck V; Ebert K; Hoyler T; d'Hargues Y; Göppert N; Croxford AL; Waisman A; Tanriver Y; Diefenbach A
Nature; 2013 Feb; 494(7436):261-5. PubMed ID: 23334414
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Satoh-Takayama N
Int Immunol; 2016 Jan; 28(1):29-34. PubMed ID: 26462712
[TBL] [Abstract][Full Text] [Related]
5. ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice.
Deng T; Suo C; Chang J; Yang R; Li J; Cai T; Qiu J
Cell Mol Immunol; 2020 Feb; 17(2):163-177. PubMed ID: 30760919
[TBL] [Abstract][Full Text] [Related]
6. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
7. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.
Montaldo E; Teixeira-Alves LG; Glatzer T; Durek P; Stervbo U; Hamann W; Babic M; Paclik D; Stölzel K; Gröne J; Lozza L; Juelke K; Matzmohr N; Loiacono F; Petronelli F; Huntington ND; Moretta L; Mingari MC; Romagnani C
Immunity; 2014 Dec; 41(6):988-1000. PubMed ID: 25500367
[TBL] [Abstract][Full Text] [Related]
8. Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
Tachó-Piñot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin IH; Dent A; Harada Y; Finlay C; Mjösberg J; Withers DR; Hepworth MR
Cell Rep; 2023 Nov; 42(11):113425. PubMed ID: 37950867
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial transcription factor A in RORγt
Fu Z; Dean JW; Xiong L; Dougherty MW; Oliff KN; Chen ZE; Jobin C; Garrett TJ; Zhou L
Nat Commun; 2021 Jul; 12(1):4462. PubMed ID: 34294718
[TBL] [Abstract][Full Text] [Related]
10. Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s.
Li Y; Ge J; Zhao X; Xu M; Gou M; Xie B; Huang J; Sun Q; Sun L; Bai X; Tan S; Wang X; Dong C
J Exp Med; 2023 Apr; 220(4):. PubMed ID: 36651876
[TBL] [Abstract][Full Text] [Related]
11. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells.
Tizian C; Lahmann A; Hölsken O; Cosovanu C; Kofoed-Branzk M; Heinrich F; Mashreghi MF; Kruglov A; Diefenbach A; Neumann C
Elife; 2020 Feb; 9():. PubMed ID: 32039762
[TBL] [Abstract][Full Text] [Related]
12. A
Chang D; Zhang H; Ge J; Xing Q; Guo X; Wang X; Dong C
Front Immunol; 2023; 14():1105145. PubMed ID: 36969227
[TBL] [Abstract][Full Text] [Related]
13. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
Guo X; Qiu J; Tu T; Yang X; Deng L; Anders RA; Zhou L; Fu YX
Immunity; 2014 Jan; 40(1):25-39. PubMed ID: 24412612
[TBL] [Abstract][Full Text] [Related]
14. ZBTB46 in ILC3: shared transcriptional infrastructure defines gut-protective capabilities.
Curio S; Belz GT
Trends Immunol; 2022 Sep; 43(9):690-692. PubMed ID: 35953346
[TBL] [Abstract][Full Text] [Related]
15. A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut.
Teng F; Goc J; Zhou L; Chu C; Shah MA; Eberl G; Sonnenberg GF
Sci Immunol; 2019 Oct; 4(40):. PubMed ID: 31586011
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Hao J; Liu C; Gu Z; Yang X; Lan X; Guo X
Nat Commun; 2024 Apr; 15(1):2820. PubMed ID: 38561332
[TBL] [Abstract][Full Text] [Related]
17. Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity.
Qi X; Qiu J; Chang J; Ji Y; Yang Q; Cui G; Sun L; Chai Q; Qin J; Qiu J
Mucosal Immunol; 2021 Jan; 14(1):38-52. PubMed ID: 32612160
[TBL] [Abstract][Full Text] [Related]
18. DOCK8 controls survival of group 3 innate lymphoid cells in the gut through Cdc42 activation.
Aihara R; Kunimura K; Watanabe M; Uruno T; Yamane N; Sakurai T; Sakata D; Nishimura F; Fukui Y
Int Immunol; 2021 Mar; 33(3):149-160. PubMed ID: 32986079
[TBL] [Abstract][Full Text] [Related]
19. ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.
Teng F; Tachó-Piñot R; Sung B; Farber DL; Worgall S; Hammad H; Lambrecht BN; Hepworth MR; Sonnenberg GF
Cell Rep; 2021 Nov; 37(8):110051. PubMed ID: 34818549
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
Qiu J; Zhou L
Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]